Please check your internet connection and try again.
# Ecospirin (Aspirin Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to delay dissolution until the drug reaches the small intestine, reducing gastric irritation.
## Primary Indications
* Pain and inflammation (mild to moderate)
* Fever
* Prevention of cardiovascular events (e.g., myocardial infarction, stroke) in specific patient populations.
## Adult Dosing
* **Pain/Fever/Inflammation:** Typically 325 mg to 650 mg orally every 4 to 6 hours as needed. Maximum daily dose is generally 4000 mg.
* **Cardiovascular Prevention:** Dosing varies based on indication and risk. Common doses include 81 mg, 162 mg, or 325 mg orally once daily. Specific dosing should follow established guidelines or prescriber recommendations.
## Pediatric Dosing
Aspirin is generally **not recommended** for use in children and adolescents with viral infections (e.g., influenza, varicella) due to the risk of Reye's syndrome. When indicated for other reasons (e.g., Kawasaki disease), dosing is weight-based and should be determined by a specialist.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised.
## Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* History of aspirin-induced asthma, urticaria, or allergic-type reactions.
* Active peptic ulceration or gastrointestinal bleeding.
* Bleeding disorders.
* Severe hepatic or renal impairment.
* Concomitant use with methotrexate in high doses.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, heartburn, abdominal pain, GI bleeding, ulceration.
* **Hematologic:** Increased bleeding time, bruising.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, dizziness, headache.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Methotrexate:** Increased risk of methotrexate toxicity, especially at higher aspirin doses.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, beta-blockers):** May decrease antihypertensive efficacy.
* **Uricosuric agents (e.g., probenecid):** May reduce efficacy.
## Monitoring
* Signs and symptoms of GI bleeding (melena, hematemesis, abdominal pain).
* Signs of bruising or excessive bleeding.
* Renal and hepatic function, especially in patients with pre-existing conditions or those on long-term therapy.
* Tinnitus, which may indicate overdosage.
## Clinical Pearls
* The enteric coating allows for administration once daily for cardiovascular prevention, reducing dosing frequency.
* Enteric-coated aspirin should be swallowed whole and not crushed, cut, or chewed to maintain the coating integrity.
* Patients should be advised to report any signs of GI bleeding or unusual bleeding/bruising promptly.
* While generally considered safe for cardiovascular prevention, the risk of bleeding must be weighed against the benefit for each individual patient.
***
**Disclaimer:** This information is intended for healthcare professionals and does not replace the need to consult the official prescribing information or other authoritative drug compendia. Dosing and recommendations may vary based on specific patient factors, clinical guidelines, and local protocols. Always verify current prescribing information before making clinical decisions.
